Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Sims

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Infectious Diseases and Therapy|August 30, 2024
Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDIColleen S Kraft, Matthew Sims, Michael Silverman, et al.
NEJM Evidence|August 4, 2023
Colistin Monotherapy versus Combination Therapy for Carbapenem-Resistant OrganismsKeith S Kaye, Dror Marchaim, Visanu Thamlikitkul, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2025
The Impact of Synergistic Therapy Between Colistin and Meropenem on Outcomes of Patients With Pneumonia or Bloodstream Infection Due to Carbapenem-Resistant Gram-Negative PathogensMariya Huralska, Jason M Pogue, Michael Rybak, et al.
Lancet (London, England)|February 12, 2008
LDL-cholesterol concentrations: a genome-wide association studyManjinder S Sandhu, Dawn M Waterworth, Sally L Debenham, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 6, 2026
The Impact of Colistin MIC on Clinical Failure and Mortality: Insights from the OVERCOME TrialJason M Pogue, Michael J Rybak, Jacinda C Abdul-Mutakabbir, et al.
JAMA|September 29, 2018
Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical TrialThomas L Holland, Issam Raad, Helen W Boucher, et al.
Function (Oxford, England)|December 16, 2025
Opportunities for RNA sequencing in physiology: from big data to understanding homeostasis and heterogeneityJeremy W Prokop, Stephanie M Bilinovich, Ember Tokarski, et al.
JAMA|August 13, 2025
Dalbavancin for Treatment of Staphylococcus aureus Bacteremia: The DOTS Randomized Clinical TrialNicholas A Turner, Toshimitsu Hamasaki, Sarah B Doernberg, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Infectious Diseases and Therapy|August 30, 2024
Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDIColleen S Kraft, Matthew Sims, Michael Silverman, et al.
NEJM Evidence|August 4, 2023
Colistin Monotherapy versus Combination Therapy for Carbapenem-Resistant OrganismsKeith S Kaye, Dror Marchaim, Visanu Thamlikitkul, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2025
The Impact of Synergistic Therapy Between Colistin and Meropenem on Outcomes of Patients With Pneumonia or Bloodstream Infection Due to Carbapenem-Resistant Gram-Negative PathogensMariya Huralska, Jason M Pogue, Michael Rybak, et al.
Lancet (London, England)|February 12, 2008
LDL-cholesterol concentrations: a genome-wide association studyManjinder S Sandhu, Dawn M Waterworth, Sally L Debenham, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 6, 2026
The Impact of Colistin MIC on Clinical Failure and Mortality: Insights from the OVERCOME TrialJason M Pogue, Michael J Rybak, Jacinda C Abdul-Mutakabbir, et al.
JAMA|September 29, 2018
Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical TrialThomas L Holland, Issam Raad, Helen W Boucher, et al.
Function (Oxford, England)|December 16, 2025
Opportunities for RNA sequencing in physiology: from big data to understanding homeostasis and heterogeneityJeremy W Prokop, Stephanie M Bilinovich, Ember Tokarski, et al.
JAMA|August 13, 2025
Dalbavancin for Treatment of Staphylococcus aureus Bacteremia: The DOTS Randomized Clinical TrialNicholas A Turner, Toshimitsu Hamasaki, Sarah B Doernberg, et al.
Pageof 4